nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—S1PR1—umbilical vein—colon cancer	0.0646	0.14	CbGeAlD
Fingolimod—S1PR1—endothelium—colon cancer	0.0306	0.0662	CbGeAlD
Fingolimod—S1PR1—blood vessel—colon cancer	0.0282	0.061	CbGeAlD
Fingolimod—S1PR4—lymphoid tissue—colon cancer	0.0172	0.0372	CbGeAlD
Fingolimod—CYP4F2—renal system—colon cancer	0.0163	0.0352	CbGeAlD
Fingolimod—S1PR4—bone marrow—colon cancer	0.0157	0.0338	CbGeAlD
Fingolimod—S1PR3—smooth muscle tissue—colon cancer	0.015	0.0325	CbGeAlD
Fingolimod—S1PR5—lymphoid tissue—colon cancer	0.0145	0.0312	CbGeAlD
Fingolimod—S1PR1—epithelium—colon cancer	0.0138	0.0297	CbGeAlD
Fingolimod—CYP4F2—digestive system—colon cancer	0.0134	0.0289	CbGeAlD
Fingolimod—S1PR1—smooth muscle tissue—colon cancer	0.0132	0.0286	CbGeAlD
Fingolimod—SPHK1—smooth muscle tissue—colon cancer	0.0131	0.0283	CbGeAlD
Fingolimod—X-linked lymphoproliferative syndrome—Methotrexate—colon cancer	0.0127	0.0516	CcSEcCtD
Fingolimod—Lymphoproliferative disorder—Methotrexate—colon cancer	0.0127	0.0516	CcSEcCtD
Fingolimod—SPHK1—renal system—colon cancer	0.0126	0.0273	CbGeAlD
Fingolimod—CYP4F2—bone marrow—colon cancer	0.0123	0.0266	CbGeAlD
Fingolimod—S1PR3—lymphoid tissue—colon cancer	0.012	0.0259	CbGeAlD
Fingolimod—CYP4F2—vagina—colon cancer	0.0118	0.0255	CbGeAlD
Fingolimod—S1PR5—liver—colon cancer	0.0106	0.023	CbGeAlD
Fingolimod—S1PR1—lymphoid tissue—colon cancer	0.0106	0.0229	CbGeAlD
Fingolimod—CYP4F2—liver—colon cancer	0.00997	0.0215	CbGeAlD
Fingolimod—CYP4F12—digestive system—colon cancer	0.00994	0.0215	CbGeAlD
Fingolimod—S1PR4—lymph node—colon cancer	0.00971	0.021	CbGeAlD
Fingolimod—S1PR1—vagina—colon cancer	0.00924	0.02	CbGeAlD
Fingolimod—CYP4F12—bone marrow—colon cancer	0.00917	0.0198	CbGeAlD
Fingolimod—SPHK1—vagina—colon cancer	0.00914	0.0197	CbGeAlD
Fingolimod—S1PR3—liver—colon cancer	0.00884	0.0191	CbGeAlD
Fingolimod—CYP4F12—vagina—colon cancer	0.00878	0.019	CbGeAlD
Fingolimod—Herpes virus infection—Capecitabine—colon cancer	0.00829	0.0338	CcSEcCtD
Fingolimod—S1PR5—lymph node—colon cancer	0.00816	0.0176	CbGeAlD
Fingolimod—S1PR1—liver—colon cancer	0.00779	0.0168	CbGeAlD
Fingolimod—CYP4F12—liver—colon cancer	0.00741	0.016	CbGeAlD
Fingolimod—S1PR3—lymph node—colon cancer	0.00678	0.0146	CbGeAlD
Fingolimod—Lower respiratory tract infection—Capecitabine—colon cancer	0.00674	0.0275	CcSEcCtD
Fingolimod—Lymphopenia—Irinotecan—colon cancer	0.00672	0.0274	CcSEcCtD
Fingolimod—Cerebral haemorrhage—Vincristine—colon cancer	0.00638	0.026	CcSEcCtD
Fingolimod—S1PR1—lymph node—colon cancer	0.00598	0.0129	CbGeAlD
Fingolimod—SPHK1—lymph node—colon cancer	0.00591	0.0128	CbGeAlD
Fingolimod—CYP4F12—lymph node—colon cancer	0.00568	0.0123	CbGeAlD
Fingolimod—Depressed mood—Capecitabine—colon cancer	0.00515	0.021	CcSEcCtD
Fingolimod—Lymphoma—Methotrexate—colon cancer	0.0049	0.02	CcSEcCtD
Fingolimod—Lymphopenia—Capecitabine—colon cancer	0.0045	0.0183	CcSEcCtD
Fingolimod—Visual acuity reduced—Capecitabine—colon cancer	0.00387	0.0158	CcSEcCtD
Fingolimod—Blood triglycerides increased—Capecitabine—colon cancer	0.00351	0.0143	CcSEcCtD
Fingolimod—Herpes zoster—Capecitabine—colon cancer	0.00306	0.0125	CcSEcCtD
Fingolimod—Cerebrovascular accident—Irinotecan—colon cancer	0.00255	0.0104	CcSEcCtD
Fingolimod—Cardiac arrest—Vincristine—colon cancer	0.00244	0.00993	CcSEcCtD
Fingolimod—Cardiac arrest—Irinotecan—colon cancer	0.00237	0.00967	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Vincristine—colon cancer	0.00231	0.00941	CcSEcCtD
Fingolimod—Herpes zoster—Methotrexate—colon cancer	0.00228	0.00927	CcSEcCtD
Fingolimod—Cardiac arrest—Fluorouracil—colon cancer	0.00227	0.00927	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00225	0.00916	CcSEcCtD
Fingolimod—CYP2E1—renal system—colon cancer	0.00204	0.00442	CbGeAlD
Fingolimod—Weight decreased—Vincristine—colon cancer	0.002	0.00817	CcSEcCtD
Fingolimod—Pneumonia—Vincristine—colon cancer	0.00199	0.0081	CcSEcCtD
Fingolimod—Depression—Vincristine—colon cancer	0.00197	0.00803	CcSEcCtD
Fingolimod—Weight decreased—Irinotecan—colon cancer	0.00195	0.00796	CcSEcCtD
Fingolimod—Pneumonia—Irinotecan—colon cancer	0.00193	0.00789	CcSEcCtD
Fingolimod—Gastroenteritis—Capecitabine—colon cancer	0.00188	0.00768	CcSEcCtD
Fingolimod—Pneumonia—Fluorouracil—colon cancer	0.00185	0.00755	CcSEcCtD
Fingolimod—Eye pain—Capecitabine—colon cancer	0.00185	0.00754	CcSEcCtD
Fingolimod—Infestation—Fluorouracil—colon cancer	0.00184	0.00751	CcSEcCtD
Fingolimod—Infestation NOS—Fluorouracil—colon cancer	0.00184	0.00751	CcSEcCtD
Fingolimod—Hepatic enzyme increased—Methotrexate—colon cancer	0.00181	0.00738	CcSEcCtD
Fingolimod—Bradycardia—Irinotecan—colon cancer	0.00176	0.00717	CcSEcCtD
Fingolimod—Connective tissue disorder—Vincristine—colon cancer	0.00174	0.0071	CcSEcCtD
Fingolimod—Sinusitis—Fluorouracil—colon cancer	0.00173	0.00704	CcSEcCtD
Fingolimod—Cerebrovascular accident—Capecitabine—colon cancer	0.0017	0.00695	CcSEcCtD
Fingolimod—CYP2E1—lymphoid tissue—colon cancer	0.0017	0.00367	CbGeAlD
Fingolimod—Connective tissue disorder—Irinotecan—colon cancer	0.0017	0.00692	CcSEcCtD
Fingolimod—CYP2E1—digestive system—colon cancer	0.00168	0.00362	CbGeAlD
Fingolimod—Cardiac disorder—Vincristine—colon cancer	0.00165	0.00671	CcSEcCtD
Fingolimod—CYP3A4—renal system—colon cancer	0.00165	0.00355	CbGeAlD
Fingolimod—Migraine—Capecitabine—colon cancer	0.00164	0.0067	CcSEcCtD
Fingolimod—CYP2D6—renal system—colon cancer	0.00162	0.0035	CbGeAlD
Fingolimod—SPHK1—Fc-epsilon receptor I signaling in mast cells—PIK3CA—colon cancer	0.00161	0.00552	CbGpPWpGaD
Fingolimod—Angiopathy—Vincristine—colon cancer	0.00161	0.00656	CcSEcCtD
Fingolimod—Cardiac disorder—Irinotecan—colon cancer	0.0016	0.00653	CcSEcCtD
Fingolimod—Mediastinal disorder—Vincristine—colon cancer	0.0016	0.00651	CcSEcCtD
Fingolimod—Cardiac arrest—Capecitabine—colon cancer	0.00159	0.00647	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—ODC1—colon cancer	0.00157	0.00539	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—CHST5—colon cancer	0.00157	0.00539	CbGpPWpGaD
Fingolimod—Alopecia—Vincristine—colon cancer	0.00157	0.00639	CcSEcCtD
Fingolimod—Angiopathy—Irinotecan—colon cancer	0.00157	0.00639	CcSEcCtD
Fingolimod—Mediastinal disorder—Irinotecan—colon cancer	0.00156	0.00634	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—DLC1—colon cancer	0.00155	0.00533	CbGpPWpGaD
Fingolimod—Mental disorder—Vincristine—colon cancer	0.00155	0.00633	CcSEcCtD
Fingolimod—Liver function test abnormal—Capecitabine—colon cancer	0.00154	0.00629	CcSEcCtD
Fingolimod—Alopecia—Irinotecan—colon cancer	0.00153	0.00622	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.0015	0.00613	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—DLC1—colon cancer	0.0015	0.00513	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—DLC1—colon cancer	0.0015	0.00513	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—CTNNB1—colon cancer	0.00149	0.00512	CbGpPWpGaD
Fingolimod—Back pain—Vincristine—colon cancer	0.00149	0.00609	CcSEcCtD
Fingolimod—SPHK1—Fc-epsilon receptor I signaling in mast cells—HRAS—colon cancer	0.00149	0.00511	CbGpPWpGaD
Fingolimod—S1PR1—Fc-epsilon receptor I signaling in mast cells—AKT1—colon cancer	0.00149	0.0051	CbGpPWpGaD
Fingolimod—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00147	0.00601	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—MUC2—colon cancer	0.00146	0.00502	CbGpPWpGaD
Fingolimod—Alopecia—Fluorouracil—colon cancer	0.00146	0.00596	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—LGR5—colon cancer	0.00146	0.00501	CbGpPWpGaD
Fingolimod—Back pain—Irinotecan—colon cancer	0.00145	0.00593	CcSEcCtD
Fingolimod—Influenza—Capecitabine—colon cancer	0.00144	0.00589	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—CTNNB1—colon cancer	0.00141	0.00484	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—LGR5—colon cancer	0.00141	0.00482	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—LGR5—colon cancer	0.00141	0.00482	CbGpPWpGaD
Fingolimod—Bronchitis—Capecitabine—colon cancer	0.00139	0.00566	CcSEcCtD
Fingolimod—Leukopenia—Vincristine—colon cancer	0.00138	0.00563	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—DLC1—colon cancer	0.00136	0.00466	CbGpPWpGaD
Fingolimod—Vision blurred—Fluorouracil—colon cancer	0.00136	0.00553	CcSEcCtD
Fingolimod—SPHK1—Metabolism—ODC1—colon cancer	0.00135	0.00463	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CHST5—colon cancer	0.00135	0.00463	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—SRC—colon cancer	0.00135	0.00463	CbGpPWpGaD
Fingolimod—CYP3A4—digestive system—colon cancer	0.00135	0.00291	CbGeAlD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—SRC—colon cancer	0.00135	0.00462	CbGpPWpGaD
Fingolimod—Leukopenia—Irinotecan—colon cancer	0.00135	0.00548	CcSEcCtD
Fingolimod—Hypertension—Vincristine—colon cancer	0.00133	0.00543	CcSEcCtD
Fingolimod—CYP2D6—digestive system—colon cancer	0.00133	0.00287	CbGeAlD
Fingolimod—SPHK1—Fc-epsilon receptor I signaling in mast cells—AKT1—colon cancer	0.00132	0.00451	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—VEGFA—colon cancer	0.00132	0.00451	CbGpPWpGaD
Fingolimod—Cough—Irinotecan—colon cancer	0.00131	0.00535	CcSEcCtD
Fingolimod—Weight decreased—Capecitabine—colon cancer	0.00131	0.00532	CcSEcCtD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—NRAS—colon cancer	0.0013	0.00446	CbGpPWpGaD
Fingolimod—Hypertension—Irinotecan—colon cancer	0.0013	0.00529	CcSEcCtD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—NRAS—colon cancer	0.0013	0.00445	CbGpPWpGaD
Fingolimod—Pneumonia—Capecitabine—colon cancer	0.00129	0.00528	CcSEcCtD
Fingolimod—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.00129	0.00443	CbGpPWpGaD
Fingolimod—Leukopenia—Fluorouracil—colon cancer	0.00129	0.00525	CcSEcCtD
Fingolimod—Infestation NOS—Capecitabine—colon cancer	0.00129	0.00525	CcSEcCtD
Fingolimod—Infestation—Capecitabine—colon cancer	0.00129	0.00525	CcSEcCtD
Fingolimod—Depression—Capecitabine—colon cancer	0.00128	0.00523	CcSEcCtD
Fingolimod—CYP2E1—Metapathway biotransformation—CHST5—colon cancer	0.00128	0.00439	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—LGR5—colon cancer	0.00128	0.00438	CbGpPWpGaD
Fingolimod—SPHK1—Signaling by VEGF—SRC—colon cancer	0.00128	0.00437	CbGpPWpGaD
Fingolimod—Cerebrovascular accident—Methotrexate—colon cancer	0.00127	0.00517	CcSEcCtD
Fingolimod—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.00125	0.0043	CbGpPWpGaD
Fingolimod—Infection—Vincristine—colon cancer	0.00125	0.0051	CcSEcCtD
Fingolimod—CYP2E1—liver—colon cancer	0.00125	0.0027	CbGeAlD
Fingolimod—SPHK1—Signaling by VEGF—VEGFA—colon cancer	0.00124	0.00426	CbGpPWpGaD
Fingolimod—Nervous system disorder—Vincristine—colon cancer	0.00124	0.00504	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—NRAS—colon cancer	0.00123	0.00421	CbGpPWpGaD
Fingolimod—Infection—Irinotecan—colon cancer	0.00122	0.00497	CcSEcCtD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—MYC—colon cancer	0.00121	0.00414	CbGpPWpGaD
Fingolimod—Nervous system disorder—Irinotecan—colon cancer	0.0012	0.0049	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—DLC1—colon cancer	0.0012	0.00412	CbGpPWpGaD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—SRC—colon cancer	0.00119	0.00409	CbGpPWpGaD
Fingolimod—Hypotension—Vincristine—colon cancer	0.00118	0.0048	CcSEcCtD
Fingolimod—Bradycardia—Capecitabine—colon cancer	0.00118	0.0048	CcSEcCtD
Fingolimod—Infection—Fluorouracil—colon cancer	0.00117	0.00476	CcSEcCtD
Fingolimod—Nervous system disorder—Fluorouracil—colon cancer	0.00115	0.0047	CcSEcCtD
Fingolimod—Liver function test abnormal—Methotrexate—colon cancer	0.00115	0.00468	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—NRAS—colon cancer	0.00115	0.00394	CbGpPWpGaD
Fingolimod—Hypotension—Irinotecan—colon cancer	0.00115	0.00467	CcSEcCtD
Fingolimod—Connective tissue disorder—Capecitabine—colon cancer	0.00114	0.00463	CcSEcCtD
Fingolimod—Paraesthesia—Vincristine—colon cancer	0.00113	0.00461	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—LGR5—colon cancer	0.00113	0.00387	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—KRAS—colon cancer	0.00112	0.00384	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—KRAS—colon cancer	0.00112	0.00383	CbGpPWpGaD
Fingolimod—Paraesthesia—Irinotecan—colon cancer	0.0011	0.00449	CcSEcCtD
Fingolimod—Hypotension—Fluorouracil—colon cancer	0.0011	0.00448	CcSEcCtD
Fingolimod—Dyspnoea—Irinotecan—colon cancer	0.00109	0.00446	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Vincristine—colon cancer	0.00109	0.00443	CcSEcCtD
Fingolimod—Fatigue—Vincristine—colon cancer	0.00109	0.00443	CcSEcCtD
Fingolimod—Eye disorder—Capecitabine—colon cancer	0.00108	0.0044	CcSEcCtD
Fingolimod—Cardiac disorder—Capecitabine—colon cancer	0.00107	0.00437	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—MYC—colon cancer	0.00107	0.00367	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Irinotecan—colon cancer	0.00106	0.00432	CcSEcCtD
Fingolimod—Fatigue—Irinotecan—colon cancer	0.00106	0.00431	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—KRAS—colon cancer	0.00106	0.00362	CbGpPWpGaD
Fingolimod—Paraesthesia—Fluorouracil—colon cancer	0.00106	0.0043	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—AXIN2—colon cancer	0.00105	0.0036	CbGpPWpGaD
Fingolimod—Angiopathy—Capecitabine—colon cancer	0.00105	0.00427	CcSEcCtD
Fingolimod—Dyspnoea—Fluorouracil—colon cancer	0.00105	0.00427	CcSEcCtD
Fingolimod—Mediastinal disorder—Capecitabine—colon cancer	0.00104	0.00425	CcSEcCtD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—PIK3CA—colon cancer	0.00103	0.00352	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—PIK3CA—colon cancer	0.00103	0.00352	CbGpPWpGaD
Fingolimod—Alopecia—Capecitabine—colon cancer	0.00102	0.00416	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00101	0.00413	CcSEcCtD
Fingolimod—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.00101	0.00347	CbGpPWpGaD
Fingolimod—Mental disorder—Capecitabine—colon cancer	0.00101	0.00413	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—AXIN2—colon cancer	0.00101	0.00346	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AXIN2—colon cancer	0.00101	0.00346	CbGpPWpGaD
Fingolimod—CYP3A4—liver—colon cancer	0.00101	0.00217	CbGeAlD
Fingolimod—CYP2D6—liver—colon cancer	0.000989	0.00214	CbGeAlD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—KRAS—colon cancer	0.000988	0.00339	CbGpPWpGaD
Fingolimod—Back pain—Capecitabine—colon cancer	0.000973	0.00397	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—PIK3CA—colon cancer	0.00097	0.00333	CbGpPWpGaD
Fingolimod—Pneumonia—Methotrexate—colon cancer	0.000964	0.00393	CcSEcCtD
Fingolimod—Infestation—Methotrexate—colon cancer	0.000958	0.00391	CcSEcCtD
Fingolimod—Infestation NOS—Methotrexate—colon cancer	0.000958	0.00391	CcSEcCtD
Fingolimod—Depression—Methotrexate—colon cancer	0.000956	0.00389	CcSEcCtD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—HRAS—colon cancer	0.000951	0.00326	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—HRAS—colon cancer	0.000949	0.00325	CbGpPWpGaD
Fingolimod—Vision blurred—Capecitabine—colon cancer	0.000948	0.00386	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—AXIN2—colon cancer	0.000917	0.00314	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—CHST5—colon cancer	0.000908	0.00311	CbGpPWpGaD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—PIK3CA—colon cancer	0.000908	0.00311	CbGpPWpGaD
Fingolimod—Asthenia—Vincristine—colon cancer	0.000904	0.00368	CcSEcCtD
Fingolimod—Leukopenia—Capecitabine—colon cancer	0.000901	0.00367	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—HRAS—colon cancer	0.000898	0.00308	CbGpPWpGaD
Fingolimod—Palpitations—Capecitabine—colon cancer	0.000889	0.00362	CcSEcCtD
Fingolimod—Asthenia—Irinotecan—colon cancer	0.00088	0.00359	CcSEcCtD
Fingolimod—Cough—Capecitabine—colon cancer	0.000878	0.00358	CcSEcCtD
Fingolimod—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000872	0.00299	CbGpPWpGaD
Fingolimod—Hypertension—Capecitabine—colon cancer	0.000869	0.00354	CcSEcCtD
Fingolimod—Diarrhoea—Vincristine—colon cancer	0.000862	0.00351	CcSEcCtD
Fingolimod—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.000853	0.00292	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000851	0.00347	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—HRAS—colon cancer	0.00084	0.00288	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—AKT1—colon cancer	0.00084	0.00288	CbGpPWpGaD
Fingolimod—Diarrhoea—Irinotecan—colon cancer	0.000839	0.00342	CcSEcCtD
Fingolimod—Dizziness—Vincristine—colon cancer	0.000833	0.0034	CcSEcCtD
Fingolimod—Pruritus—Fluorouracil—colon cancer	0.000831	0.00339	CcSEcCtD
Fingolimod—Infection—Capecitabine—colon cancer	0.000816	0.00332	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—AXIN2—colon cancer	0.000812	0.00278	CbGpPWpGaD
Fingolimod—Dizziness—Irinotecan—colon cancer	0.000811	0.00331	CcSEcCtD
Fingolimod—Nervous system disorder—Capecitabine—colon cancer	0.000805	0.00328	CcSEcCtD
Fingolimod—Eye disorder—Methotrexate—colon cancer	0.000804	0.00328	CcSEcCtD
Fingolimod—Diarrhoea—Fluorouracil—colon cancer	0.000804	0.00328	CcSEcCtD
Fingolimod—Cardiac disorder—Methotrexate—colon cancer	0.000799	0.00325	CcSEcCtD
Fingolimod—Skin disorder—Capecitabine—colon cancer	0.000798	0.00325	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—AKT1—colon cancer	0.000793	0.00272	CbGpPWpGaD
Fingolimod—Headache—Vincristine—colon cancer	0.000789	0.00322	CcSEcCtD
Fingolimod—Angiopathy—Methotrexate—colon cancer	0.000781	0.00318	CcSEcCtD
Fingolimod—Dizziness—Fluorouracil—colon cancer	0.000777	0.00317	CcSEcCtD
Fingolimod—Mediastinal disorder—Methotrexate—colon cancer	0.000775	0.00316	CcSEcCtD
Fingolimod—Headache—Irinotecan—colon cancer	0.000769	0.00313	CcSEcCtD
Fingolimod—Hypotension—Capecitabine—colon cancer	0.000767	0.00313	CcSEcCtD
Fingolimod—Alopecia—Methotrexate—colon cancer	0.00076	0.0031	CcSEcCtD
Fingolimod—Mental disorder—Methotrexate—colon cancer	0.000754	0.00307	CcSEcCtD
Fingolimod—Paraesthesia—Capecitabine—colon cancer	0.000737	0.00301	CcSEcCtD
Fingolimod—Headache—Fluorouracil—colon cancer	0.000736	0.003	CcSEcCtD
Fingolimod—Dyspnoea—Capecitabine—colon cancer	0.000732	0.00298	CcSEcCtD
Fingolimod—Back pain—Methotrexate—colon cancer	0.000724	0.00295	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Capecitabine—colon cancer	0.000709	0.00289	CcSEcCtD
Fingolimod—Fatigue—Capecitabine—colon cancer	0.000708	0.00289	CcSEcCtD
Fingolimod—Vision blurred—Methotrexate—colon cancer	0.000706	0.00288	CcSEcCtD
Fingolimod—Leukopenia—Methotrexate—colon cancer	0.00067	0.00273	CcSEcCtD
Fingolimod—Cough—Methotrexate—colon cancer	0.000654	0.00266	CcSEcCtD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000649	0.00223	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000633	0.00258	CcSEcCtD
Fingolimod—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000611	0.00209	CbGpPWpGaD
Fingolimod—Infection—Methotrexate—colon cancer	0.000607	0.00248	CcSEcCtD
Fingolimod—Nervous system disorder—Methotrexate—colon cancer	0.000599	0.00244	CcSEcCtD
Fingolimod—Skin disorder—Methotrexate—colon cancer	0.000594	0.00242	CcSEcCtD
Fingolimod—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000594	0.00203	CbGpPWpGaD
Fingolimod—Asthenia—Capecitabine—colon cancer	0.000589	0.0024	CcSEcCtD
Fingolimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000582	0.00199	CbGpPWpGaD
Fingolimod—Pruritus—Capecitabine—colon cancer	0.000581	0.00237	CcSEcCtD
Fingolimod—Hypotension—Methotrexate—colon cancer	0.000571	0.00233	CcSEcCtD
Fingolimod—Diarrhoea—Capecitabine—colon cancer	0.000562	0.00229	CcSEcCtD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000558	0.00191	CbGpPWpGaD
Fingolimod—Paraesthesia—Methotrexate—colon cancer	0.000549	0.00224	CcSEcCtD
Fingolimod—Dyspnoea—Methotrexate—colon cancer	0.000545	0.00222	CcSEcCtD
Fingolimod—Dizziness—Capecitabine—colon cancer	0.000543	0.00221	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Methotrexate—colon cancer	0.000528	0.00215	CcSEcCtD
Fingolimod—Fatigue—Methotrexate—colon cancer	0.000527	0.00215	CcSEcCtD
Fingolimod—Headache—Capecitabine—colon cancer	0.000514	0.0021	CcSEcCtD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000511	0.00175	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—ABCB1—colon cancer	0.000481	0.00165	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—TYMS—colon cancer	0.000473	0.00162	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000439	0.0015	CbGpPWpGaD
Fingolimod—Asthenia—Methotrexate—colon cancer	0.000439	0.00179	CcSEcCtD
Fingolimod—Pruritus—Methotrexate—colon cancer	0.000432	0.00176	CcSEcCtD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000425	0.00146	CbGpPWpGaD
Fingolimod—Diarrhoea—Methotrexate—colon cancer	0.000418	0.0017	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—ABCB1—colon cancer	0.000416	0.00142	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—TYMS—colon cancer	0.000408	0.0014	CbGpPWpGaD
Fingolimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000405	0.00139	CbGpPWpGaD
Fingolimod—Dizziness—Methotrexate—colon cancer	0.000404	0.00165	CcSEcCtD
Fingolimod—Headache—Methotrexate—colon cancer	0.000383	0.00156	CcSEcCtD
Fingolimod—CYP2E1—Metabolism—CA7—colon cancer	0.000366	0.00126	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000365	0.00125	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ABCB1—colon cancer	0.000357	0.00122	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—TYMS—colon cancer	0.000351	0.0012	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—CTNNB1—colon cancer	0.000339	0.00116	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PPARG—colon cancer	0.000335	0.00115	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.000314	0.00108	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—FGFR3—colon cancer	0.000303	0.00104	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—FGFR3—colon cancer	0.000292	0.001	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—FGFR3—colon cancer	0.000292	0.001	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PPARG—colon cancer	0.000289	0.000991	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—APC—colon cancer	0.000278	0.000954	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—NRAS—colon cancer	0.000278	0.000954	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.00027	0.000926	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—APC—colon cancer	0.000268	0.000918	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—APC—colon cancer	0.000268	0.000918	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—NRAS—colon cancer	0.000268	0.000918	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—NRAS—colon cancer	0.000268	0.000918	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—FGFR3—colon cancer	0.000265	0.000908	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTGS2—colon cancer	0.000264	0.000903	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—BRAF—colon cancer	0.000262	0.000897	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CA7—colon cancer	0.00026	0.000891	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—EGFR—colon cancer	0.000253	0.000869	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—BRAF—colon cancer	0.000252	0.000863	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—BRAF—colon cancer	0.000252	0.000863	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PPARG—colon cancer	0.000248	0.000852	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—EGFR—colon cancer	0.000244	0.000837	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—EGFR—colon cancer	0.000244	0.000837	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—APC—colon cancer	0.000243	0.000834	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—NRAS—colon cancer	0.000243	0.000834	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—PIK3CA—colon cancer	0.000242	0.000831	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—KRAS—colon cancer	0.000239	0.000821	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—FGFR3—colon cancer	0.000234	0.000804	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—PIK3CA—colon cancer	0.000233	0.0008	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—PIK3CA—colon cancer	0.000233	0.0008	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—KRAS—colon cancer	0.000231	0.00079	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—KRAS—colon cancer	0.000231	0.00079	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—BRAF—colon cancer	0.000229	0.000784	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTGS2—colon cancer	0.000227	0.00078	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CHST5—colon cancer	0.000222	0.000761	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ODC1—colon cancer	0.000222	0.000761	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—EGFR—colon cancer	0.000222	0.00076	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—PIK3CA—colon cancer	0.00022	0.000754	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—EP300—colon cancer	0.000219	0.000751	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—APC—colon cancer	0.000215	0.000738	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PIK3CA—colon cancer	0.000212	0.000726	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PIK3CA—colon cancer	0.000212	0.000726	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—PIK3CA—colon cancer	0.000212	0.000726	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—KRAS—colon cancer	0.000209	0.000718	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—HRAS—colon cancer	0.000204	0.000698	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—BRAF—colon cancer	0.000202	0.000694	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—AKT1—colon cancer	0.000198	0.000679	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CASP3—colon cancer	0.000196	0.000672	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—HRAS—colon cancer	0.000196	0.000672	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—HRAS—colon cancer	0.000196	0.000672	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGS2—colon cancer	0.000195	0.00067	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—PIK3CA—colon cancer	0.000192	0.000659	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCND1—colon cancer	0.000191	0.000654	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—AKT1—colon cancer	0.000191	0.000653	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—AKT1—colon cancer	0.000191	0.000653	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—EP300—colon cancer	0.000189	0.000649	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CTNNB1—colon cancer	0.000189	0.000648	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CASP3—colon cancer	0.000189	0.000647	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CASP3—colon cancer	0.000189	0.000647	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CDKN1A—colon cancer	0.000185	0.000633	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCND1—colon cancer	0.000184	0.00063	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCND1—colon cancer	0.000184	0.00063	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CTNNB1—colon cancer	0.000182	0.000624	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CTNNB1—colon cancer	0.000182	0.000624	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—AKT1—colon cancer	0.00018	0.000616	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HRAS—colon cancer	0.000178	0.00061	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CDKN1A—colon cancer	0.000178	0.000609	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CDKN1A—colon cancer	0.000178	0.000609	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EP300—colon cancer	0.000176	0.000602	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—AKT1—colon cancer	0.000173	0.000593	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—AKT1—colon cancer	0.000173	0.000593	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—AKT1—colon cancer	0.000173	0.000593	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CASP3—colon cancer	0.000171	0.000588	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SRC—colon cancer	0.000171	0.000586	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CA7—colon cancer	0.00017	0.000582	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EP300—colon cancer	0.000169	0.00058	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EP300—colon cancer	0.000169	0.00058	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCND1—colon cancer	0.000167	0.000572	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VEGFA—colon cancer	0.000166	0.00057	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CTNNB1—colon cancer	0.000165	0.000566	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SRC—colon cancer	0.000164	0.000564	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SRC—colon cancer	0.000164	0.000564	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NRAS—colon cancer	0.000164	0.000563	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—EP300—colon cancer	0.000163	0.000557	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PIK3CA—colon cancer	0.000162	0.000556	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDKN1A—colon cancer	0.000161	0.000553	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VEGFA—colon cancer	0.00016	0.000549	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VEGFA—colon cancer	0.00016	0.000549	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NRAS—colon cancer	0.000158	0.000542	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NRAS—colon cancer	0.000158	0.000542	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ODC1—colon cancer	0.000157	0.00054	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CHST5—colon cancer	0.000157	0.00054	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—AKT1—colon cancer	0.000157	0.000539	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EP300—colon cancer	0.000154	0.000526	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MYC—colon cancer	0.000153	0.000525	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TGFB1—colon cancer	0.000153	0.000524	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CASP3—colon cancer	0.000152	0.00052	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EGFR—colon cancer	0.00015	0.000513	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SRC—colon cancer	0.000149	0.000512	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCND1—colon cancer	0.000148	0.000506	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MYC—colon cancer	0.000147	0.000505	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MYC—colon cancer	0.000147	0.000505	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TGFB1—colon cancer	0.000147	0.000504	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TGFB1—colon cancer	0.000147	0.000504	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CTNNB1—colon cancer	0.000146	0.000501	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VEGFA—colon cancer	0.000145	0.000499	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EGFR—colon cancer	0.000144	0.000494	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EGFR—colon cancer	0.000144	0.000494	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NRAS—colon cancer	0.000144	0.000493	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDKN1A—colon cancer	0.000143	0.00049	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KRAS—colon cancer	0.000141	0.000485	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PIK3CA—colon cancer	0.00014	0.00048	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KRAS—colon cancer	0.000136	0.000467	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KRAS—colon cancer	0.000136	0.000467	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EP300—colon cancer	0.000136	0.000466	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MYC—colon cancer	0.000134	0.000459	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TGFB1—colon cancer	0.000133	0.000458	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—AKT1—colon cancer	0.000132	0.000454	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SRC—colon cancer	0.000132	0.000453	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EGFR—colon cancer	0.000131	0.000449	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PIK3CA—colon cancer	0.00013	0.000446	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VEGFA—colon cancer	0.000129	0.000441	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NRAS—colon cancer	0.000127	0.000436	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—colon cancer	0.000126	0.000431	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PIK3CA—colon cancer	0.000125	0.000429	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PIK3CA—colon cancer	0.000125	0.000429	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KRAS—colon cancer	0.000124	0.000424	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—colon cancer	0.000121	0.000415	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—colon cancer	0.000121	0.000415	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HRAS—colon cancer	0.00012	0.000412	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CA—colon cancer	0.00012	0.000412	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MYC—colon cancer	0.000118	0.000406	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TGFB1—colon cancer	0.000118	0.000405	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—colon cancer	0.000116	0.000397	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HRAS—colon cancer	0.000116	0.000397	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HRAS—colon cancer	0.000116	0.000397	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—AKT1—colon cancer	0.000114	0.000392	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CA—colon cancer	0.000114	0.000389	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—colon cancer	0.00011	0.000377	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KRAS—colon cancer	0.000109	0.000375	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AKT1—colon cancer	0.000106	0.000364	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HRAS—colon cancer	0.000105	0.00036	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ODC1—colon cancer	0.000103	0.000353	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CHST5—colon cancer	0.000103	0.000353	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AKT1—colon cancer	0.000102	0.00035	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AKT1—colon cancer	0.000102	0.00035	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CA—colon cancer	0.000101	0.000345	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—AKT1—colon cancer	9.82e-05	0.000337	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—colon cancer	9.73e-05	0.000333	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HRAS—colon cancer	9.3e-05	0.000319	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AKT1—colon cancer	9.28e-05	0.000318	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AKT1—colon cancer	8.21e-05	0.000282	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCB1—colon cancer	5.86e-05	0.000201	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TYMS—colon cancer	5.76e-05	0.000197	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCB1—colon cancer	4.16e-05	0.000143	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TYMS—colon cancer	4.09e-05	0.00014	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPARG—colon cancer	4.08e-05	0.00014	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—colon cancer	3.21e-05	0.00011	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARG—colon cancer	2.89e-05	9.92e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCB1—colon cancer	2.72e-05	9.32e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TYMS—colon cancer	2.67e-05	9.16e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—EP300—colon cancer	2.67e-05	9.15e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—colon cancer	2.28e-05	7.81e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CA—colon cancer	1.97e-05	6.77e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—EP300—colon cancer	1.89e-05	6.49e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARG—colon cancer	1.89e-05	6.49e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKT1—colon cancer	1.61e-05	5.53e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—colon cancer	1.49e-05	5.1e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CA—colon cancer	1.4e-05	4.8e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—EP300—colon cancer	1.24e-05	4.24e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKT1—colon cancer	1.14e-05	3.92e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CA—colon cancer	9.16e-06	3.14e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKT1—colon cancer	7.48e-06	2.56e-05	CbGpPWpGaD
